SJ733
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SJ733, covering 2020-04-15 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria [Phase 2]